COMPARISON OF STATISTICAL METHODS USED TO MODEL HEALTH CARE COSTS BY DIALYSIS MODALITY IN THE TREATMENT OF KIDNEY FAILURE

Author(s)

Chui BKY, Klarenbach SUniversity of Alberta, Edmonton, AB, Canada

OBJECTIVES: There is controversy regarding the most appropriate method to analyze cost data. We examined the role of censoring, model fit and assumption violations in a study determining the costs of dialysis modality for the treatment of kidney failure. METHODS: All incident dialysis patients from Alberta from 1999 to 2003 were tracked for direct medical costs (inpatient and outpatient costs, physician claims, and medication costs) for three years using administrative datasets, and categorized into peritoneal dialysis (PD) only, hemodialysis (HD) only, or modality switches (HD to PD; PD to HD). Unadjusted censored and uncensored cumulative costs were determined using the non-parametric method of Lin and bootstrapping.  Model fit and assumption violations for alternate covariate adjusted regression models were assessed through comparison of various approaches (OLS or GLM regression, log-transformation, smearing), and the optimal approach identified. RESULTS: Three year adjusted cumulative costs for patients receiving PD only and HD to PD groups were $58,724 ($44,123-$73,325; 95% confidence interval) and $114,503 ($96,318-$132,688) respectively, and were significantly lower than patients receiving HD only $175,996 ($134,787-$217,205) and PD technique failure patients $173,308 ($147,725-$119,891).  Comparison of censored and uncensored unadjusted total cumulative costs yielded similar results.  Covariate adjusted GLM regression was the best fit for modeling total cumulative costs when compared to other OLS and GLM models.  For cost categories with smaller sample sizes (inpatient costs; n=674), GLM models fitted poorly due to kurtosis, and OLS regression on log-transformed costs with smearing yielded better less biased estimates.  CONCLUSIONS: GLM regression methods for estimating costs performed well when applied to our analyses with larger datasets (n>1000), but gave biased results when smaller datasets were used.  When modeling costs with smaller sample sizes, the most appropriate regression method can be determined through model diagnostics.

Conference/Value in Health Info

2012-06, ISPOR 2012, Washington, D.C., USA

Value in Health, Vol. 15, No. 4 (June 2012)

Code

PMD25

Topic

Economic Evaluation

Topic Subcategory

Cost-comparison, Effectiveness, Utility, Benefit Analysis

Disease

Urinary/Kidney Disorders

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×